Effects of volume-based procurement policy on the usage and expenditure of first-generation targeted drugs for non-small cell lung cancer with EGFR mutation in China: an interrupted time series study

OBJECTIVES: In December 2018, China launched national volume-based procurement (NVBP) to negotiate drug prices with manufacturers. Gefitinib was one of the 25 pilot drugs, which is used for treatment of non-small cell lung cancer. Lung cancer is the most common type of cancer in China and targeted d...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiaoyang, Huang, Huang, Sun, Yan, Zhu, Zheng, Jiang, Bin, Yang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Health Policy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335569/
https://www.ncbi.nlm.nih.gov/pubmed/37407064
http://dx.doi.org/10.1136/bmjopen-2022-064199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335569/
https://www.ncbi.nlm.nih.gov/pubmed/37407064
http://dx.doi.org/10.1136/bmjopen-2022-064199

Ejemplares similares